Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
megamergers
Pharma
Experts propose ways to tighten FTC's pharma M&A oversight
The FTC will likely adopt a holistic approach, which may discourage large pharma deals, Berenberg analysts said.
Angus Liu
Jun 16, 2022 11:34am
2022 forecast: After a slow 2021, will biopharma M&A tick up?
Dec 22, 2021 9:55am
AbbVie dodges hedge fund lawsuit over failed $55B Shire pursuit
Sep 14, 2021 4:00pm
AstraZeneca's $39B Alexion buy clears final antitrust hurdle
Jul 14, 2021 6:01am
FTC kicks off review of biopharma industry's deal-making
Mar 16, 2021 4:33pm
M&A poised to rebound, fueled by pharma's $1.47T war chest
Dec 22, 2020 3:00am
